1800 202 8726
Timing around treatment

PET-CT After — Growth Factor Injections

If you have had a G-CSF injection recently, a PET-CT scan may show alarming changes throughout your skeleton that have nothing to do with your cancer. Timing the scan correctly prevents a frightening and misleading result.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Benign but convincing — The marrow and spleen changes from growth factors can look identical to cancer spread in bone — even to an experienced radiologist.
  • Timing is the fix — Allowing enough time between your last injection and the scan prevents the false alarm entirely.
  • Both teams need to know — The oncologist prescribing G-CSF and the nuclear medicine team reading the scan must both know your injection schedule.
  • Not all products are the same — Long-acting single-dose products stay active longer than daily injections, so the required wait differs by product.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Growth factor injections (G-CSF) given after chemotherapy stimulate the bone marrow so strongly that the entire skeleton and spleen light up on PET-CT. This pattern can look identical to cancer spread in bone. Your oncology and nuclear medicine teams should coordinate your scan timing around the last injection — that is what prevents a misleading result.

CION offers PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.

Why does a G-CSF injection make a PET-CT scan look alarming?

G-CSF tells your bone marrow to produce white blood cells rapidly. That process uses far more glucose than usual, and PET-CT measures glucose consumption. The result is intense, diffuse uptake throughout the skeleton — spine, pelvis, ribs, and the long bones.

The spleen often shows the same change. When the marrow is working at full capacity, the spleen contributes to blood cell production, and that activity appears on the scan.

Neither finding is related to cancer. The problem is that the pattern looks nearly identical to bone disease or lymphoma in the marrow. A radiologist without the injection history is looking at an image that cannot be reliably read.

What to confirm before booking your PET-CT

  • Tell your oncologist the date of your last G-CSF injection before the scan is scheduled.
  • Make sure the nuclear medicine team also knows — even if you think your oncologist has already passed this on.
  • Ask whether the product you received — daily short-acting or single long-acting — changes how long you need to wait.
  • If the scan cannot be delayed, confirm that the nuclear medicine physician will be told the injection date before writing the report.
  • If a scan has already been done too soon, do not act on any bone findings until your oncologist knows about the timing.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What the radiologist sees: with and without recent G-CSF

FindingNo recent G-CSFAfter recent G-CSF
Bone marrowMild, low-level uptakeIntense, diffuse uptake throughout the skeleton
SpleenNormal size, low uptakeEnlarged, with increased uptake
ResemblesNormal baselineWidespread bone disease or marrow lymphoma
Reliable for bone staging?YesUnreliable without documented injection history
Action neededRoutine readingNuclear medicine team must know the injection schedule

Did you know?

The marrow and spleen changes from G-CSF can cover the entire skeleton — spine, pelvis, ribs, and long bones — so completely that the image is indistinguishable from lymphoma in the marrow or widespread bone metastases. The changes are temporary and reverse once the drug has cleared the system.

This is why the injection history is not optional information. It is what makes the scan interpretable.

Source: EANM procedural guidelines for FDG PET/CT tumour imaging

Timing decisions in practice

How long after my last injection is it safe to have the PET-CT?

There is no single number that works across all patients and all products. EANM and SNMMI procedural guidelines recommend allowing several weeks between the last growth factor injection and a staging or restaging PET-CT. The exact interval depends on which product you received and your clinical situation. Your oncologist and nuclear medicine physician should agree before the scan is booked — this is not a decision for the scheduling desk to make alone.

Does it matter which G-CSF product I received?

Yes. Daily short-acting filgrastim clears more quickly than long-acting products such as pegfilgrastim, which is designed to provide sustained marrow stimulation over a longer period. The required wait after a long-acting product is generally longer than after daily injections. Your oncologist knows which product you received; make sure the nuclear medicine team has the same information before your scan date is confirmed.

What if the scan was already done before anyone knew there was a timing problem?

The scan is not necessarily wasted. A radiologist who knows the injection history can recognise the expected pattern and still give reliable information about lymph nodes, organs, and soft tissue. What causes harm is acting on alarming bone findings without knowing about the injection timing. If your report mentions diffuse marrow uptake, ask your oncologist whether the injection history was in the referral before the report was written. If it was not, a repeat scan at the right interval may be needed.

What if the scan cannot be delayed because the treatment decision is urgent?

That is a clinical judgement your oncologist must make. When urgency outweighs uncertainty, the nuclear medicine physician must be told the exact injection date and product before the scan proceeds. The report can then distinguish what the injection effect explains from what remains genuinely concerning. The scan can still give reliable information about lymph nodes and organs even when the bone marrow signal cannot be fully relied on. Do not let the scan proceed without both teams knowing the full picture.

My report mentions possible bone disease. Could the injections explain it?

It is worth raising, especially if you had G-CSF in the weeks before the scan. Diffuse, symmetric uptake throughout the skeleton is far more consistent with a drug effect than with cancer spread. A focal finding in a single bone is a different matter. Ask your oncologist whether the injection history was documented in the referral, and whether the radiologist knew about it before writing the report. If not, a repeat scan at the appropriate interval may be needed before any conclusion about bone disease is drawn.

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.

Explore 30 more Specialised Tracers and How PET-CT Compares topics

All Specialised Tracers and How PET-CT Compares →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

How long should I wait after a G-CSF injection before having a PET-CT?

The wait depends on which product you received. EANM and SNMMI procedural guidelines recommend several weeks between the last growth factor injection and a staging or restaging scan, with the exact interval depending on the product and your situation. Daily short-acting products clear more quickly than long-acting single-dose ones. Your oncologist and nuclear medicine physician should agree on the specific timing before the scan is booked.

Does diffuse marrow uptake on my PET report mean cancer has spread to bone?

Not necessarily — and if you had G-CSF before the scan, it probably does not. Diffuse, symmetric uptake throughout the skeleton is a well-recognised effect of marrow stimulation, not a finding specific to cancer. The risk is that a radiologist interpreting the image without knowing the injection history may read it as disease. Ask your oncologist whether the injection timing was documented before the report was written.

Can the radiologist tell from the image alone that G-CSF caused the uptake?

Not reliably. The pattern — intense, diffuse marrow uptake throughout the skeleton, often with an enlarged active spleen — is characteristic, and a radiologist who knows the injection history will recognise it. Without that information, the same image is genuinely difficult to distinguish from lymphoma in the marrow or widespread bone metastases. Providing the injection history before the scan is what makes reliable interpretation possible.

The spleen also appeared enlarged on my scan. Is that from the injections?

Yes, if you had G-CSF before the scan. When the marrow is working at full capacity, the spleen contributes to blood cell production, and that activity shows on PET as enlargement with increased uptake. This is an expected effect of the drug and does not indicate cancer in the spleen. Like the marrow changes, it reverses once the drug has cleared the system.

What should I tell the nuclear medicine team when I arrive for the scan?

Tell them the name of your G-CSF product and the date of your last injection — even if you think your oncologist has already communicated this. It is easy for the information not to reach the radiologist who reads the scan. Ask whether it is noted in your referral. If it is not, ask the team to record it before the scan begins.

Who should I contact if I am not sure whether enough time has passed?

Contact your oncologist first. They know your injection schedule and can advise on whether the interval is sufficient. Your oncologist should then confirm directly with the nuclear medicine team before the scan date is finalised. It is reasonable to ask your oncologist to make that contact rather than leaving it to chance — the decision should not rest with you alone.

Call now Book free consultation